Advances in superenzyme gene therapy in penile rehabilitation / 中华男科学杂志
National Journal of Andrology
;
(12): 350-354, 2013.
Artículo
en Chino
| WPRIM
| ID: wpr-256906
ABSTRACT
Erectile dysfunction (ED) is an almost unavoidable complication of radical prostatectomy. At present, though the concept of penile rehabilitation (PR) is accepted by most clinicians, the outcomes of erectile function recovery vary widely. Prostacyclin (PGI2) is a prostanoid and a main vasoprotectant which induces smooth muscle relaxation, but not used for replacement therapy because of its high unstability. SuperEnzyme is capable of continuous, specific and targeted promotion of PGI2 synthesis, and helps PR in ED patients after radical prostatectomy. SuperEnzyme gene therapy has a promising prospect for PR and the management of ED. This review updates SuperEnzyme gene therapy in PR.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pene
/
Rehabilitación
/
Terapéutica
/
Erección Peniana
/
Terapia Genética
/
Epoprostenol
/
Prostaglandina-Endoperóxido Sintasas
/
Terapia Enzimática
/
Disfunción Eréctil
/
Metabolismo
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS